Literature DB >> 6285817

In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.

R A Greenfield, T A Kurzynski, W A Craig.   

Abstract

The in vitro susceptibility of 20 isolates of Clostridium difficile to cefotaxime, moxalactam, and cefoperazone was determined by a standard agar dilution method. The median minimal inhibitory concentrations were 64, 32, and 32 mug/ml for cefotaxime, moxalactam, and cefoperazone, respectively.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6285817      PMCID： PMC182026          DOI： 10.1128/AAC.21.5.846

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Antimicrobial agent-associated colitis and diarrhea.

Authors:  W L George
Journal:  West J Med       Date:  1980-08

2.  In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.

Authors:  J Dzink; J G Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

3.  Cephalosporin-associated pseudomembranous colitis due to Clostridium difficile.

Authors:  J G Bartlett; S H Willey; T W Chang; B Lowe
Journal:  JAMA       Date:  1979-12-14       Impact factor: 56.272

4.  Cephalosporin-associated pseudomembranous colitis.

Authors:  D F Hutcheon; F D Milligan; J H Yardley; T R Hendrix
Journal:  Am J Dig Dis       Date:  1978-04

5.  Human pharmacology of cefotaxime (HR 756), a new cephalosporin.

Authors:  R Lüthy; R Münch; J Blaser; H Bhend; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

6.  Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis.

Authors:  J G Bartlett
Journal:  Johns Hopkins Med J       Date:  1981-07

7.  Evaluation of eight cephalosporins in hamster colitis model.

Authors:  J R Ebright; R Fekety; J Silva; K H Wilson
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

8.  Cephalosporin-associated pseudomembranous colitis.

Authors:  J F Tures; W F Townsend; H D Rose
Journal:  JAMA       Date:  1976-08-23       Impact factor: 56.272

9.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

10.  Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.

Authors:  A Leroy; G Humbert; J P Fillastre
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191
View more
  1 in total

Review 1.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.